- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04904822
Abdominal Versus Vaginal Bisection in Laparoscopic Hysterectomy (TLH-Bisection)
March 11, 2024 updated by: Ayman S Dawood, MD, Tanta University
Abdominal Versus Vaginal Uterine Bisection for Retrieval of Large Uteri During Laparoscopic Hysterectomy: A Randomized Controlled Study
Large uteri present a challenge during Total lap.hysterectomy and its extraction is another challenge.
This study addressees and compare 2 methods of retrieval of large uteri
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Despite a number of publications about TLH for large uterus, few surgeons have compared the results of their technique of TLH through the vagina or abdominal bisection.
The aim of this study was to compare the clinical results of TLH for large uterus through transvaginal or abdominal bisection approaches after strict preoperative assessment.
Study Type
Interventional
Enrollment (Actual)
66
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ayman Dawood, MD
- Phone Number: +202020972067
- Email: ayman.dawood@med.tanta.edu.eg
Study Contact Backup
- Name: Adel Elgergawy, MD
- Phone Number: +201002057250
- Email: dradelali775@gmail.com
Study Locations
-
-
Gharbia
-
Tanta, Gharbia, Egypt, 31111
- Tanta University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- large uterus ≥ 12weeks,
- benign pathology,
- mobile uterus
- BMI less than 30kg/m2
Exclusion Criteria:
- unfit for laparoscopy,
- Extensive pelvic adhesions,
- Extensive endometriosis
- malignancy
- virgin cases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Study group
Vaginal bisection of uterus
|
Uterine bisection vaginally by scalpel 24
|
Experimental: Control group
Abdominal bisection
|
Uterine bisection by endokinfe
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Retrieval time of uterus
Time Frame: 6 months
|
Time from end of colpotomy to extraction of uterus
|
6 months
|
Blood loss
Time Frame: 6 months
|
Amount of blood in suction
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Injury of other organs
Time Frame: 6 months
|
Number of cases with intraoperative injuries
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2021
Primary Completion (Actual)
October 31, 2023
Study Completion (Actual)
January 31, 2024
Study Registration Dates
First Submitted
May 24, 2021
First Submitted That Met QC Criteria
May 24, 2021
First Posted (Actual)
May 27, 2021
Study Record Updates
Last Update Posted (Actual)
March 13, 2024
Last Update Submitted That Met QC Criteria
March 11, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- uterine bisection
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
we will share results and statistical analysis on valuable request
IPD Sharing Time Frame
3 months
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hysterectomy
-
Zuyderland Medisch CentrumCatharina Ziekenhuis EindhovenRecruitingHysterectomy | Natural Orifice Transluminal Endoscopic Surgery | Vaginal HysterectomyNetherlands
-
Muğla Sıtkı Koçman UniversityCompletedAbdominal Hysterectomy | Laparoscopic Hysterectomy
-
Università degli Studi di FerraraRecruiting
-
GCS Ramsay Santé pour l'Enseignement et la RechercheCompleted
-
University Hospitals Cleveland Medical CenterWithdrawn
-
Atlantic Health SystemUnknownHysterectomyUnited States
-
Brigham and Women's HospitalMassachusetts General HospitalCompletedHysterectomyUnited States
-
Case Comprehensive Cancer CenterWithdrawnHysterectomy
-
Cairo UniversityUnknown
-
Mayo ClinicTerminated
Clinical Trials on Vaginal bisection
-
Walter Reed National Military Medical CenterUnknown
-
Baylor College of MedicineEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsTerminatedVaginal StrictureUnited States
-
National Institute of Allergy and Infectious Diseases...Johns Hopkins University; Inova Health Care Services; Rutgers UniversityRecruitingObesity, Childhood | Cesarean Delivery Affecting Newborn | Microbiota | Gastrointestinal Microbiome | Intestinal Microbiome | Host Microbial InteractionsUnited States
-
University of Wisconsin, MadisonTerminatedSexual Dysfunction, PhysiologicalUnited States
-
University Hospital, BordeauxCompletedMatrix Metalloproteinases and Human Papillomavirus in Dysplasias and Cancers of the Cervix (MMP-HPV)Papillomavirus Infections | Cervix Cancer | Dysplasia
-
Cairo UniversityCompletedFirst Trimester AbortionEgypt
-
TriHealth Inc.CompletedVaginal Packing Following Pelvic Reconstructive SurgeryUnited States
-
University Hospital, GhentRecruiting
-
Università degli Studi dell'InsubriaUnknown
-
Tampere University HospitalCompleted